Find clinical trials for Breast Cancer in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Durham, NC, USA:
This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...
Phase 2
Durham, North Carolina, United States and 3 other locations
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Durham, North Carolina, United States and 19 other locations
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...
Phase 2
Chapel Hill, North Carolina, United States and 27 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Chapel Hill, North Carolina, United States of America and 9 other locations
triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...
Phase 2
Durham, North Carolina, United States and 9 other locations
This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and whi ...
Phase 2
Chapel Hill, North Carolina, United States and 6 other locations
This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...
Phase 2
Durham, North Carolina, United States and 16 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Chapel Hill, North Carolina, United States and 32 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Durham, North Carolina, United States and 117 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Durham, North Carolina, United States and 50 other locations
Clinical trials
Research sites
Resources
Legal